FDA plans public workshop on ctDNA tests February 14, 2020 -- The U.S. Food and Drug Administration (FDA) is planning to hold a public workshop on March 9 on the development of circulating tumor DNA (ctDNA) tests for cancer screening.
FDA seeks help to prevent vaping-related lung injuries February 14, 2020 -- The U.S. Food and Drug Administration (FDA) has issued a public call for more information to help prevent future vaping-related injuries. The agency is asking for information on substances used by vapers and ways to make vaping products tamper-proof.
Coronavirus test gets CMS billing code February 13, 2020 -- The U.S. Centers for Medicare and Medicaid Services (CMS) has developed a billing code in the Healthcare Common Procedure Coding System to be used by labs and facilities testing patients for the novel coronavirus, which is now being called SARS-CoV-2 (formerly 2019-nCoV).
Native Antigen releases coronavirus antigens February 13, 2020 -- The Native Antigen Co. has introduced a line of coronavirus antigens from the emerging Wuhan strain, a move it said will support research and the development of diagnostics and vaccines.
CAP backs new surprise billing legislation February 12, 2020 -- The College of American Pathologists (CAP) is strongly backing new legislation by the House Ways and Means Committee on surprise billing, noting that it includes an arbitration process for resolving claims and does not have a threshold for this to kick in.
BD partners with Babson on retail blood testing February 12, 2020 -- Becton Dickinson (BD) and Babson Diagnostics are expanding their collaborative work to include the development of a new blood collection device that does not involve accessing a vein and is practical for use in the retail pharmacy setting.
WHO officially names coronavirus disease COVID-19 February 12, 2020 -- The World Health Organization (WHO) on February 11 announced an official designation for the disease caused by the novel coronavirus (2019-nCoV), naming the condition COVID-19.